Envestnet Portfolio Solutions Inc. Has $778,000 Stock Position in The Clorox Company $CLX

Envestnet Portfolio Solutions Inc. decreased its position in The Clorox Company (NYSE:CLX) by 77.6% in the 2nd quarter, HoldingsChannel reports. The fund owned 6,475 shares of the company’s stock after selling 22,441 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Clorox were worth $778,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. American National Bank & Trust raised its holdings in shares of Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after buying an additional 89 shares in the last quarter. Ransom Advisory Ltd acquired a new position in shares of Clorox in the 1st quarter worth approximately $35,000. GW&K Investment Management LLC raised its holdings in shares of Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after buying an additional 208 shares in the last quarter. Ameritas Advisory Services LLC acquired a new position in shares of Clorox in the 2nd quarter worth approximately $48,000. Finally, Roble Belko & Company Inc raised its holdings in shares of Clorox by 140.7% in the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock worth $53,000 after buying an additional 211 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Up 1.8%

Shares of CLX opened at $119.73 on Monday. The Clorox Company has a 52 week low of $116.53 and a 52 week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The firm has a market capitalization of $14.58 billion, a price-to-earnings ratio of 18.36, a PEG ratio of 0.99 and a beta of 0.52. The business’s fifty day moving average price is $121.61 and its two-hundred day moving average price is $127.58.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s revenue was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is presently 76.07%.

Analysts Set New Price Targets

CLX has been the subject of several analyst reports. Wells Fargo & Company cut their price target on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. TD Cowen cut their price target on shares of Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a report on Wednesday, October 1st. Zacks Research upgraded Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 29th. Finally, UBS Group decreased their price target on Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $130.20.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.